KRTAP19-1 Inhibitors
KRTAP19-1 inhibitors are chemical compounds that target the keratin-associated protein 19-1 (KRTAP19-1), which belongs to the broader family of keratin-associated proteins. These proteins are key structural components that interact with keratins in the hair and other keratinized tissues. KRTAPs, including KRTAP19-1, contribute to the stability, mechanical strength, and function of keratin fibers. KRTAP19-1, in particular, plays a role in the formation and structure of hair by binding to keratin filaments, forming a matrix that crosslinks the keratin fibers into stable structures. Inhibitors of KRTAP19-1 work by modulating or disrupting its interaction with keratin, which could potentially alter the properties of keratinized tissues.
The chemical structures of KRTAP19-1 inhibitors vary widely depending on the specific target mechanism they exploit. These inhibitors may work by binding directly to the KRTAP19-1 protein, hindering its ability to form complexes with keratin, or by altering post-translational modifications necessary for KRTAP19-1 function. Such inhibitors are often designed through detailed analysis of the protein's structure and its binding sites. Structural biology techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy may aid in characterizing the interaction between KRTAP19-1 and its inhibitors. Understanding these interactions can provide insights into the specific conformational changes or biochemical pathways modulated by these inhibitors.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine could demethylate the promoter region of the KRTAP19-1 gene, potentially leading to a decrease in its expression by altering transcription factor binding affinity. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
By inhibiting histone deacetylase, Trichostatin A could increase histone acetylation near the KRTAP19-1 gene, which might suppress transcription if this gene is negatively regulated by histone acetylation. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D binds to double-stranded DNA, obstructing RNA polymerase movement, which would result in a decrease in KRTAP19-1 mRNA synthesis due to premature transcription termination. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A binds to DNA in a sequence-specific manner, which could competitively inhibit transcription factor binding at the KRTAP19-1 promoter, resulting in decreased gene expression. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid could downregulate KRTAP19-1 expression by binding to retinoic acid receptors that alter the transcriptional activity of genes, including possibly repressing KRTAP19-1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR signaling, which can suppress cap-dependent translation, potentially leading to a reduction in KRTAP19-1 protein levels despite its mRNA being present. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 would inhibit the PI3K/Akt pathway, which could decrease the transcriptional activity of genes downstream of this pathway, including potentially KRTAP19-1. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
By inhibiting JNK, SP600125 could decrease activation of transcription factors that are required for KRTAP19-1 expression, leading to lower levels of this protein. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 inhibits the MAPK/ERK pathway, which might result in the suppression of transcription factors that enhance KRTAP19-1 gene expression. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide halts translational elongation, which would lead to a reduction in KRTAP19-1 protein synthesis by preventing the assembly of this protein on ribosomes. | ||||||